Projects
Applications are now open for 2024 admissions. Applications will close on 1 December 2023 at 12 noon.
| ID | Title | Internal supervisors | Phase |
|---|---|---|---|
| NDORMS 2024/13 NDORMS 2024/13 | Towards equity in medicine with big health data, epidemiology, and artificial intelligence Towards equity in medicine with big health data, epidemiology, and artificial intelligence | Sara Khalid, Laura Coates, Danielle Newby, Gary Collins | 2024 |
| NDORMS 2024/14 NDORMS 2024/14 | Artificial Intelligence for climate-health mitigation and adaptation Artificial Intelligence for climate-health mitigation and adaptation | Sara Khalid, Marta Pineda, Laura Coates | 2024 |
| NDORMS 2024/1 NDORMS 2024/1 | Identify new drug targets for treating OA by inducing autophagy Identify new drug targets for treating OA by inducing autophagy | Ghada Alsaleh, James Edwards | 2024 |
| NDORMS 2024/2 NDORMS 2024/2 | Unlocking Insights from Real-World Evidence: Exploring the Safety of Drug Combinations Unlocking Insights from Real-World Evidence: Exploring the Safety of Drug Combinations | Ed Burn, Danielle Newby, Annika Jödicke, Albert Prats-Uribe, Daniel Prieto-Alhambra | 2024 |
| NDORMS 2024/3 NDORMS 2024/3 | Improving outcomes following hip fracture in Nepal (3 year studentship) Improving outcomes following hip fracture in Nepal (3 year studentship) | Matthew Costa, Jonathan Cook | 2024 |
| NDORMS 2024/4 NDORMS 2024/4 | Using long-read sequencing to identify new druggable targets in Multiple Myeloma Using long-read sequencing to identify new druggable targets in Multiple Myeloma | Adam Cribbs, Udo Oppermann, Anjan Thakurta, Sarah Gooding | 2024 |
| NDORMS 2024/5 NDORMS 2024/5 | Elucidating T cell phenotype and function in frozen shoulder Elucidating T cell phenotype and function in frozen shoulder | Stephanie Dakin | 2024 |
| NDORMS 2024/6 NDORMS 2024/6 | Sex differences and the interplay of androgens and oestrogens in the modulation of human immune responses Sex differences and the interplay of androgens and oestrogens in the modulation of human immune responses | James Fullerton, Christopher Buckley, Laura Coates | 2024 |
| NDORMS 2024/7 NDORMS 2024/7 | Psychometric sensitivity analyses for clinical trials and observational studies that use patient-reported outcome measures Psychometric sensitivity analyses for clinical trials and observational studies that use patient-reported outcome measures | Conrad Harrison, David Beard | 2024 |
| NDORMS 2024/8 NDORMS 2024/8 | Evaluating the efficacy of interventions for idiopathic toe-walking in children. Research proposal for prospective DPhil student (3-year project) Evaluating the efficacy of interventions for idiopathic toe-walking in children. Research proposal for prospective DPhil student (3-year project) | Alpesh Kothari, Julie Stebbins | 2024 |
| NDORMS 2024/9 NDORMS 2024/9 | Real world evidence in the study of different subtypes of breast, lung, and prostate cancers: phenotyping, synthetic arm trials, and target trial emulation Real world evidence in the study of different subtypes of breast, lung, and prostate cancers: phenotyping, synthetic arm trials, and target trial emulation | Daniel Prieto-Alhambra, Martí Català Sabaté | 2024 |
| NDORMS 2024/11 NDORMS 2024/11 | Identification and modification of the cellular and molecular mechanisms underlying unsuccessful knee replacements for osteoarthritis Identification and modification of the cellular and molecular mechanisms underlying unsuccessful knee replacements for osteoarthritis | Sarah Snelling, Adam Cribbs, Jolet Mimpen | 2024 |
| NDORMS 2024/12 NDORMS 2024/12 | Scaphoid fractures: Identifying the cellular targets and key molecular pathways for improved repair outcomes Scaphoid fractures: Identifying the cellular targets and key molecular pathways for improved repair outcomes | Sarah Snelling, Adam Cribbs, Philippa Hulley | 2024 |
| NDORMS 2024/10 NDORMS 2024/10 | How can trials and real-world evidence provide the best possible evidence on the benefits and risks of implantable devices? How can trials and real-world evidence provide the best possible evidence on the benefits and risks of implantable devices? | Daniel Prieto-Alhambra, Matthew Costa, David Beard, Albert Prats-Uribe, David Metcalfe | 2024 |
| NDORMS 2024/15 NDORMS 2024/15 | Resorbable antibacterial coatings for orthopaedic implants Resorbable antibacterial coatings for orthopaedic implants | Dario Carugo, Simon Abram, Abtin Alvand | 2024 |